Bluejay Diagnostics (BJDX) Share-based Compensation (QoQ) (2020 - 2025)
Bluejay Diagnostics (BJDX) Share-based Compensation (QoQ) (2020 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn |
| 10 | Bluejay Diagnostics | 4.43 Mn | 746,549.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -59.56% |
| Sep 30, 2025 | 111.71% |
| Jun 30, 2025 | -219.13% |
| Mar 31, 2025 | 150.81% |
| Dec 31, 2024 | -153.88% |
| Sep 30, 2024 | -20.27% |
| Jun 30, 2024 | -49.39% |
| Mar 31, 2024 | 176.29% |
| Dec 31, 2023 | 63.36% |
| Sep 30, 2023 | -253.35% |
| Jun 30, 2023 | -87.38% |
| Mar 31, 2023 | 150.71% |
| Dec 31, 2022 | -22.64% |
| Sep 30, 2022 | 6.70% |
| Jun 30, 2022 | -15.84% |
| Mar 31, 2022 | 482.79% |
| Dec 31, 2021 | -53.48% |
| Sep 30, 2021 | 29,902.58% |
| Jun 30, 2021 | -5.49% |
| Mar 31, 2021 | -94.46% |